Clinical Trials Search

Titlesort descending Intervention NCT ID Sponsor
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer Aspirin, Eflornithine, Laboratory Biomarker Analysis, Placebo, Telephone-Based Intervention NCT00983580 National Cancer Institute (NCI)
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules Aspirin, Laboratory Biomarker Analysis, Placebo NCT02169271 National Cancer Institute (NCI)
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Real Acupressure Band, Placebo Acupressure Band NCT01346267 University of South Florida
Acupuncture in Treating Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer Acupuncture NCT01141231 M.D. Anderson Cancer Center
Adaptation of Individual Meaning-Centered Psychotherapy for Chinese Immigrant Cancer Patients In-depth Patient Interviews, Adaptation of IMCP for Chinese Immigrant Cancer Patients NCT02112188 Memorial Sloan Kettering Cancer Center
Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and... Olanzapine, Chemotherapy (cisplatin or cyclophosphamide and doxorubicin), Antiemetic treatment (ondansetron or granisetron or palonosetron; plus dexamethasone; plus fosaprepitant or aprepitant), Placebo NCT02116530 Alliance for Clinical Trials in Oncology
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma armodafinil 150 mg, Placebo, armodafinil 250 mg NCT01781468 Alliance for Clinical Trials in Oncology
Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers Aspirin, Laboratory Biomarker Analysis, Placebo, Zileuton NCT02348203 National Cancer Institute (NCI)
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful... Aspirin, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT02521285 National Cancer Institute (NCI)
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic... behavioral intervention, mercaptopurine, standard follow-up care, compliance monitoring, questionnaire administration, laboratory biomarker analysis NCT01503632 Children's Oncology Group